DuPont Rings Closing Bell at New York Stock Exchange Marking Anticipated Spin-Off July 1 of The Chemours Company
Advances Transformation to Higher Growth, Higher Value, Global Science and Innovation Company
NEW YORK, June 29, 2015 – DuPont (NYSE: DD) today rang the NYSE Closing Bell to mark the anticipated separation of The Chemours Company (Chemours). DuPont Chair and Chief Executive Officer Ellen Kullman was joined by senior management at the bell ringing event.
“DuPont is proud to ring the closing bell on behalf of our employees, shareholders and all of our stakeholders, as we prepare to take a significant step forward in our transformation through the spin-off of Chemours,” said Kullman. “Starting July 1, we become a significantly different company that is more growth-driven, more science intensive and less cyclical – with a strong focus on the areas of major need where our science and engineering can uniquely make a difference.”
“Leveraging our innovation and global reach, and with an emphasis on cost and productivity, we are uniquely positioned to capture significant opportunities for growth and to drive compelling and sustainable value for our shareholders,” added Kullman.
A video of the bell ringing ceremony can be viewed by clicking here.
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.
This document contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about growth strategies, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, financial results and the anticipated date for Chemours common stock to begin trading on a “regular-way” basis on the NYSE, are forward looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties. Some of the important factors that could cause actual results to differ materially from those projected in any such forward looking statements are: (i) risks related to the anticipated timing of the separation through spin-off of Chemours, (ii) risks that the conditions to the separation are not satisfied, (iii) the risk that the expected benefits from the separation may not be fully realized or may take longer to realize than expected; (iv) continued validity of a private letter ruling from the IRS, which DuPont has received from the IRS, and the receipt and continued validity of a tax opinion, in form and substance acceptable to DuPont, and (v) additional factors described in DuPont's and Chemours' filings with the SEC. Neither DuPont nor Chemours undertakes any duty to update such forward-looking statements as a result of future developments or new information.
# # #